Item Type | Name |
Academic Article
|
Blepharospasm and oromandibular-laryngeal-cervical dystonia: a controlled trial of botulinum A toxin therapy.
|
Academic Article
|
Dystonia and tremor induced by peripheral trauma: predisposing factors.
|
Academic Article
|
Focal task-specific tremor and dystonia: categorization of occupational movement disorders.
|
Academic Article
|
Cranial-cervical dyskinesias: an overview.
|
Academic Article
|
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
|
Academic Article
|
Drug-induced dystonia in neuronal ceroid-lipofuscinosis.
|
Academic Article
|
Response and immunoresistance to botulinum toxin injections.
|
Academic Article
|
Outcome after stereotactic thalamotomy for dystonia and hemiballismus.
|
Academic Article
|
Post-traumatic movement disorders: central and peripheral mechanisms.
|
Academic Article
|
Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia.
|
Academic Article
|
Tardive stereotypy and other movement disorders in tardive dyskinesias.
|
Academic Article
|
Cervical dystonia as the initial presentation of Huntington's disease.
|
Academic Article
|
Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
|
Academic Article
|
Botulinum toxin: historical perspective and potential new indications.
|
Academic Article
|
Familial essential tremor in 4 kindreds. Prospects for genetic mapping.
|
Academic Article
|
Tardive and idiopathic oromandibular dystonia: a clinical comparison.
|
Academic Article
|
Hemidystonia secondary to carotid artery gunshot injury.
|
Academic Article
|
Tourettism and dystonia after subcortical stroke.
|
Academic Article
|
Thalamic surgery for movement disorders.
|
Academic Article
|
Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
|
Academic Article
|
A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia.
|
Academic Article
|
Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy.
|
Academic Article
|
Pallidotomy for generalized dystonia.
|
Academic Article
|
Dystonia in corticobasal degeneration.
|
Academic Article
|
Medical therapy and botulinum toxin in dystonia.
|
Academic Article
|
Comparison of thalamotomy and pallidotomy for the treatment of dystonia.
|
Academic Article
|
Peripherally induced oromandibular dystonia.
|
Academic Article
|
Basal ganglia neuronal discharge in primary and secondary dystonia.
|
Academic Article
|
Bruxism and cranial-cervical dystonia: is there a relationship?
|
Academic Article
|
Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm.
|
Academic Article
|
Long-term botulinum toxin efficacy, safety, and immunogenicity.
|
Academic Article
|
Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
|
Academic Article
|
Persistent dystonia possibly induced by flecainide.
|
Academic Article
|
Camptocormia: pathogenesis, classification, and response to therapy.
|
Academic Article
|
Treatment of dystonia.
|
Academic Article
|
Neurologic approach to drug-induced movement disorders: a study of 125 patients.
|
Academic Article
|
Runner's dystonia.
|
Academic Article
|
Focal hand dystonia, mirror dystonia and motor overflow.
|
Academic Article
|
Botulinum toxin in clinical practice.
|
Academic Article
|
Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.
|
Academic Article
|
Role of botulinum toxin in the treatment of cervical dystonia.
|
Academic Article
|
Essential tremor among children.
|
Academic Article
|
Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A.
|
Academic Article
|
Genetic study of an American family with DYT3 dystonia (lubag).
|
Academic Article
|
Hemidystonia-hemiatrophy syndrome.
|
Academic Article
|
Dystonia and other deformities in Parkinson's disease.
|
Academic Article
|
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans.
|
Academic Article
|
Globus pallidus deep brain stimulation in dystonia.
|
Academic Article
|
Parkinsonism and dystonia associated with adalimumab.
|
Academic Article
|
Dystonic tics in patients with Tourette's syndrome.
|
Academic Article
|
Botulinum toxin therapy for cervical dystonia.
|
Academic Article
|
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
|
Academic Article
|
The coexistence of tics and dystonia.
|
Academic Article
|
Genetics of essential tremor.
|
Academic Article
|
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A.
|
Academic Article
|
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia.
|
Academic Article
|
Therapeutic uses of botulinum toxin.
|
Academic Article
|
Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
|
Academic Article
|
Treatment of dystonia.
|
Academic Article
|
Intrathecal baclofen for intractable axial dystonia.
|
Academic Article
|
Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.
|
Academic Article
|
Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.
|
Academic Article
|
Motor overflow and mirror dystonia.
|
Academic Article
|
Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
|
Academic Article
|
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies.
|
Academic Article
|
Pain in Parkinson's disease.
|
Academic Article
|
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
|
Academic Article
|
The association of Tourette syndrome and dopa-responsive dystonia.
|
Academic Article
|
Respiratory disorders associated with dystonia.
|
Academic Article
|
Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE).
|
Academic Article
|
Dystonia in musicians.
|
Academic Article
|
Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Na?ve Subjects with Cervical Dystonia.
|
Academic Article
|
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.
|
Academic Article
|
Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia.
|
Academic Article
|
Tardive dystonia in patients with Tourette's syndrome.
|
Academic Article
|
Etiology and differential diagnosis of blepharospasm and oromandibular dystonia.
|
Academic Article
|
Blepharospasm and cranial-cervical dystonia (Meige's syndrome): familial occurrence.
|
Academic Article
|
Botulinum toxin in the treatment of dystonic tics.
|
Academic Article
|
Use of botulinum toxin in the treatment of hand dystonia.
|
Academic Article
|
Cocaine-related movement disorders.
|
Academic Article
|
Symptomatic and functional outcome of surgical treatment of cervical dystonia.
|
Academic Article
|
Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response.
|
Academic Article
|
Acoustic reflex abnormalities in cranial-cervical dystonia.
|
Academic Article
|
Focal dystonia: the role of botulinum toxin.
|
Academic Article
|
Soleus H-reflex measures in patients with focal and generalized dystonia.
|
Academic Article
|
Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia.
|
Academic Article
|
Dystonia: medical therapy and botulinum toxin.
|
Academic Article
|
Treatment of cervical dystonia with botulinum toxin.
|
Academic Article
|
Clinical correlates of response to botulinum toxin injections.
|
Academic Article
|
The effect of deep brain stimulation on quality of life in movement disorders.
|
Academic Article
|
Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23.
|
Academic Article
|
Sulpiride-induced tardive dystonia.
|
Academic Article
|
Prevalence of cervical dystonia and spasmodic torticollis in the United States general population.
|
Academic Article
|
Hemiparkinsonism-hemiatrophy syndrome.
|
Academic Article
|
Cervical dystonia: clinical findings and associated movement disorders.
|
Academic Article
|
Peripherally induced movement disorders.
|
Academic Article
|
Blepharospasm-oromandibular dystonia associated with a left cerebellopontine angle meningioma.
|
Academic Article
|
Botulinum toxin injections for cervical dystonia.
|
Academic Article
|
Respiratory problems in neurologic movement disorders.
|
Academic Article
|
Asian over-representation among patients with hemifacial spasm compared to patients with cranial-cervical dystonia.
|
Academic Article
|
Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN?, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.
|
Academic Article
|
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
|
Academic Article
|
Long-term efficacy and safety of botulinum toxin injections in dystonia.
|
Concept
|
Dystonia
|
Academic Article
|
Bilateral globus pallidus internus deep brain stimulation after bilateral pallidotomy in a patient with generalized early-onset primary dystonia.
|
Academic Article
|
Phenomenology and classification of dystonia: a consensus update.
|
Academic Article
|
Medical treatment of dystonia.
|
Academic Article
|
Descriptive epidemiology of cervical dystonia.
|
Academic Article
|
Sensory aspects of movement disorders.
|
Academic Article
|
Treatment of dystonia.
|
Academic Article
|
Designing clinical trials for dystonia.
|
Academic Article
|
Reply: dystonia after severe head injuries.
|
Academic Article
|
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy).
|
Academic Article
|
Alleviating manoeuvres (sensory tricks) in cervical dystonia.
|
Academic Article
|
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm.
|
Academic Article
|
Bilateral pallidal deep brain stimulation for X-linked dystonia-parkinsonism.
|
Academic Article
|
Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up.
|
Academic Article
|
IncobotulinumtoxinA (Xeomin?) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated.
|
Academic Article
|
Primary results from the cervical dystonia patient registry for observation of onabotulinumtoxina efficacy (CD PROBE).
|
Academic Article
|
Dopa-responsive dystonia--clinical and genetic heterogeneity.
|
Academic Article
|
Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
|
Academic Article
|
Clinimetric testing of the comprehensive cervical dystonia rating scale.
|
Academic Article
|
Clinical and genetic features of cervical dystonia in a large multicenter cohort.
|
Academic Article
|
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
|
Academic Article
|
Functional (psychogenic) saccadic oscillations and oculogyric crises.
|
Academic Article
|
"Complex" dystonia is not a category in the new 2013 consensus classification.
|
Academic Article
|
Impact of Cervical Dystonia on Work Productivity: An Analysis From a Patient Registry.
|
Academic Article
|
Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
|
Academic Article
|
Examiner manoeuvres 'sensory tricks' in functional (psychogenic) movement disorders.
|
Academic Article
|
Psychiatric associations of adult-onset focal dystonia phenotypes.
|
Academic Article
|
The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
|
Academic Article
|
Cervical dystonia and substance abuse.
|
Academic Article
|
Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose-Escalation Multicenter Study.
|
Academic Article
|
Author Correction: Dystonia.
|
Academic Article
|
Atypical Alexander disease with dystonia, retinopathy, and a brain mass mimicking astrocytoma.
|
Academic Article
|
Dystonia.
|
Academic Article
|
SPG11 Mutations Associated With a Complex Phenotype Resembling Dopa-Responsive Dystonia.
|
Academic Article
|
Predictors of alcohol responsiveness in dystonia.
|
Academic Article
|
Head tremor at disease onset: an ataxic phenotype of cervical dystonia.
|
Academic Article
|
Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study.
|
Academic Article
|
Functional gait disorders, clinical phenomenology, and classification.
|
Academic Article
|
Postural Directionality and Head Tremor in Cervical Dystonia.
|
Academic Article
|
Clinical and Demographic Characteristics of Upper Limb Dystonia.
|
Academic Article
|
Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort.
|
Academic Article
|
It's tricky: Rating alleviating maneuvers in cervical dystonia.
|
Academic Article
|
Head tremor and pain in cervical dystonia.
|
Academic Article
|
Quality of life in isolated dystonia: non-motor manifestations matter.
|
Academic Article
|
Botulinum Neurotoxin Injections in Childhood Opisthotonus.
|
Academic Article
|
Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
|
Academic Article
|
Does Raising the Arms Modify Head Tremor Severity in Cervical Dystonia?
|
Academic Article
|
Predictive modeling of spread in adult-onset isolated dystonia: Key properties and effect of tremor inclusion.
|
Academic Article
|
Treatment of dystonia and tics.
|
Academic Article
|
A Multi-center Genome-wide Association Study of Cervical Dystonia.
|
Academic Article
|
Oromandibular Dystonia: A Clinical Examination of 2,020 Cases.
|
Academic Article
|
Current Guidelines for Classifying and Diagnosing Cervical Dystonia: Empirical Evidence and Recommendations.
|
Academic Article
|
Sports-Related Dystonia.
|
Academic Article
|
Head tremor in cervical dystonia: Quantifying severity with computer vision.
|
Academic Article
|
The Conundrum of Dystonia in Essential Tremor Patients: How does One Classify these Cases?
|
Academic Article
|
Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review.
|
Academic Article
|
Secondary dystonia following parenchymal brain tumors.
|
Academic Article
|
Isolated Cervical Dystonia: Diagnosis and Classification.
|
Academic Article
|
From null to midline: changes in head posture do not predictably change head tremor in cervical dystonia.
|
Academic Article
|
Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact.
|
Academic Article
|
Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?
|
Academic Article
|
Longitudinal predictors of health-related quality of life in isolated dystonia.
|
Academic Article
|
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.
|
Academic Article
|
Is Dystonia an Immunologic Disorder?
|